Albree Tower‐Rader

1.4k total citations
47 papers, 463 citations indexed

About

Albree Tower‐Rader is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Albree Tower‐Rader has authored 47 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Albree Tower‐Rader's work include Cardiomyopathy and Myosin Studies (35 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Effects of Exercise (7 papers). Albree Tower‐Rader is often cited by papers focused on Cardiomyopathy and Myosin Studies (35 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Effects of Exercise (7 papers). Albree Tower‐Rader collaborates with scholars based in United States, United Kingdom and Spain. Albree Tower‐Rader's co-authors include Milind Y. Desai, Zoran Popović, Harry M. Lever, Divyanshu Mohananey, Andrew To, Wael A. Jaber, Deborah Kwon, Nicholas G. Smedira, Dermot Phelan and Jorge J. Betancor and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Albree Tower‐Rader

36 papers receiving 454 citations

Peers

Albree Tower‐Rader
Hye Bin Gwag South Korea
Sanderson Cauduro United States
Dominic Rogers United Kingdom
Eve Cariou France
Sneha Vakamudi United States
Albree Tower‐Rader
Citations per year, relative to Albree Tower‐Rader Albree Tower‐Rader (= 1×) peers Árpád Kormányos

Countries citing papers authored by Albree Tower‐Rader

Since Specialization
Citations

This map shows the geographic impact of Albree Tower‐Rader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albree Tower‐Rader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albree Tower‐Rader more than expected).

Fields of papers citing papers by Albree Tower‐Rader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albree Tower‐Rader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albree Tower‐Rader. The network helps show where Albree Tower‐Rader may publish in the future.

Co-authorship network of co-authors of Albree Tower‐Rader

This figure shows the co-authorship network connecting the top 25 collaborators of Albree Tower‐Rader. A scholar is included among the top collaborators of Albree Tower‐Rader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albree Tower‐Rader. Albree Tower‐Rader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shin, Joseph, Aeron Small, Carrie L. Blout Zawatsky, et al.. (2025). Longitudinal Evaluation of Genetic Hypertrophic Cardiomyopathy Penetrance and Transition to Disease in an Academic Biobank. JACC Advances. 4(2). 101520–101520. 1 indexed citations
2.
Murphy, Sean, Emily K. Zern, Albree Tower‐Rader, et al.. (2025). Multimodality Imaging Evaluation of Diseases of the Pulmonic Valve and Right Ventricular Outflow Tract for the Adult Cardiologist. Circulation Cardiovascular Imaging. 18(2). e017126–e017126.
3.
Tower‐Rader, Albree, et al.. (2025). Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study. European Heart Journal.
4.
Rowin, Ethan J., Albree Tower‐Rader, Daniele Massera, et al.. (2025). SUDDEN DEATH RISK AMONG HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH LEFT VENTRICULAR APICAL ANEURYSMS: DOES SIZE MATTER?. Journal of the American College of Cardiology. 85(12). 1251–1251.
5.
Desai, Milind Y., Sara Saberi, Jeffrey B. Geske, et al.. (2025). Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex. JACC Heart Failure. 13(6). 1037–1040. 2 indexed citations
6.
Desai, Milind Y., Kathy Wolski, Jeffrey B. Geske, et al.. (2025). Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks. JACC. Cardiovascular imaging. 18(12). 1300–1311.
7.
Lumish, Heidi, Kohei Hasegawa, Matthew J. Maurer, et al.. (2024). Prediction of New-Onset Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy Using Machine Learning. European Journal of Heart Failure. 27(2). 275–284. 4 indexed citations
8.
Akita, Keitaro, Kohei Hasegawa, Michael A. Fifer, et al.. (2024). Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels. Nutrition Metabolism and Cardiovascular Diseases. 34(6). 1352–1360. 2 indexed citations
9.
Liang, Lusha W., Kohei Hasegawa, Mathew S. Maurer, et al.. (2024). Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling. EP Europace. 26(11).
10.
Wasfy, Meagan M., Marie Foley Kijewski, Kevin Boyd, et al.. (2024). MYOCARDIAL METABOLIC EFFICIENCY IN HEALTHY ATHLETES VERSUS PATIENTS WITH NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY. Journal of the American College of Cardiology. 83(13). 2335–2335. 1 indexed citations
11.
Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2024). Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM. Circulation. 151(19). 1378–1390. 14 indexed citations
12.
Tower‐Rader, Albree, et al.. (2022). Multimodality Imaging of Progressive Aortic Valve Endocarditis: From Endophthalmitis to Aorto-Atrial Fistula. Cureus. 14(11). e31239–e31239.
13.
Takigami, A., Vikas Thondapu, Reece Goiffon, et al.. (2021). Coronary Artery Disease Reporting and Data System (CAD-RADS) Adoption: Analysis of Local Trends in a Large Academic Medical Center. Radiology Cardiothoracic Imaging. 3(3). e210016–e210016. 1 indexed citations
14.
Tower‐Rader, Albree, et al.. (2019). Anomalous Origin of Right Coronary Artery from the Non-coronary Cusp Demonstrated by Echocardiography and CT Angiography. Pediatric Cardiology. 40(2). 454–455.
15.
Young, Laura, Nicholas G. Smedira, Albree Tower‐Rader, Harry M. Lever, & Milind Y. Desai. (2018). Hypertrophic cardiomyopathy: A complex disease. Cleveland Clinic Journal of Medicine. 85(5). 399–411. 4 indexed citations
16.
Tower‐Rader, Albree, Oussama M. Wazni, & Wael A. Jaber. (2018). Intradevice Leak on Late Follow-Up after Watchman Implantation. CASE. 2(5). 192–196. 4 indexed citations
17.
Tower‐Rader, Albree, Divyanshu Mohananey, Andrew To, et al.. (2018). Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy. JACC. Cardiovascular imaging. 12(10). 1930–1942. 112 indexed citations
18.
Sperry, Brett W., Michael N. Vranian, Albree Tower‐Rader, et al.. (2017). Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. JACC. Cardiovascular imaging. 11(2). 234–242. 67 indexed citations
19.
Tower‐Rader, Albree & Deborah Kwon. (2017). Pericardial Masses, Cysts and Diverticula: A Comprehensive Review Using Multimodality Imaging. Progress in Cardiovascular Diseases. 59(4). 389–397. 21 indexed citations
20.
Tower‐Rader, Albree, Jyothy Puthumana, Jane Kruse, et al.. (2014). Effects of Septal Myectomy on Left Ventricular Diastolic Function and Left Atrial Volume in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 114(10). 1568–1572. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026